Tracking of in vivo O-GlcNAcylation in an Alzheimer’s Disease and Aging C. elegans Model
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
We investigated O-linked β-N-acetylglucosamine (O-GlcNAc), a post-translational modification, in an in vivo Caenorhabditis elegans model of Alzheimer’s Disease and aging. Employing a chemoenzymatic labeling strategy combined with an automated image processing, we analyzed both post-hatching and adult stages of wild-type N2 and transgenic strain expressing human tau V337M under the aex -3 promoter ( aex-3p ::tau(V337M)). Labeled O-GlcNAc proteins were visualized via fluorescence microscopy and quantified using a region-of-interest (ROI)-based image analysis pipeline. Morphometric characterization revealed an age-dependent increase in O-GlcNAcylation in wild-type worms, whereas the AD model showed a progressive decline. O-GlcNAc-labeled ROIs exhibited a shift from anterograde to predominantly retrograde transport in middle-aged transgenic nematodes, suggesting that aging and neurodegeneration alter O-GlcNAc trafficking dynamics, potentially reflecting impaired synaptic support or enhanced clearance in C. elegans.
Summary statement
This study uses a combination of chemoenzymatic labeling and an image processing pipeline to study O-linked N-acetyl glucosamine (post-translational modification)
